Cometriq 20 mg Alternative – Caboxen (Cabozantinib) 20 mg Capsule | Everest Pharmaceuticals
Caboxen 20 mg (Cabozantinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Cometriq (Exelixis). It belongs to the multikinase inhibitor class and is used in selected medullary thyroid cancer settings for capsule formulations; other cabozantinib formulations have different approved uses.
Active ingredient: Cabozantinib
Strength: 20 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Cometriq 80 mg Alternative – Caboxen (Cabozantinib) 80 mg Capsule | Everest Pharmaceuticals
Caboxen 80 mg (Cabozantinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Cometriq (Exelixis). It belongs to the multikinase inhibitor class and is used in selected medullary thyroid cancer settings for capsule formulations; other cabozantinib formulations have different approved uses.
Active ingredient: Cabozantinib
Strength: 80 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Lenvima 10 mg Alternative – Lenva (Lenvatinib) 10 mg Capsule | Beacon Pharmaceuticals
Lenvima 10 mg Alternative – Lenvaxen (Lenvatinib) 10 mg Capsule | Everest Pharmaceuticals
Lenvaxen 10 mg (Lenvatinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Lenvima (Eisai). It belongs to the multikinase inhibitor class and is used in selected thyroid, renal, liver and endometrial cancer regimens.
Active ingredient: Lenvatinib
Strength: 10 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Lenvima 4 mg Alternative – Lenva (Lenvatinib) 4 mg Capsule | Beacon Pharmaceuticals
Lenvima 4 mg Alternative – Lenvaxen (Lenvatinib) 4 mg Capsule | Everest Pharmaceuticals
Lenvaxen 4 mg (Lenvatinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Lenvima (Eisai). It belongs to the multikinase inhibitor class and is used in selected thyroid, renal, liver and endometrial cancer regimens.
Active ingredient: Lenvatinib
Strength: 4 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Nexavar 200 mg Alternative – Hepanib (Sorafenib) 200 mg Tablet | Everest Pharmaceuticals
Hepanib 200 mg (Sorafenib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Nexavar (Bayer). It belongs to the multikinase inhibitor class and is used in selected liver, kidney and thyroid cancers.
Active ingredient: Sorafenib
Strength: 200 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Nexavar 200 mg Alternative – Soranix (Sorafenib) 200 mg Tablet | Beacon Pharmaceuticals
Sutent 50 mg Alternative – Sunicent (Sunitinib) 50 mg Capsule | Incepta Pharmaceuticals
Sunicent 50 mg (Sunitinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Sutent (Pfizer).
Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.
Sutent 50 mg Alternative – Sunitix (Sunitinib) 50 mg Capsule | Beacon Pharmaceuticals
Votrient 200 mg Alternative – Pazorest (Pazopanib) 200 mg Tablet | Everest Pharmaceuticals
Pazorest 200 mg (Pazopanib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Votrient (Novartis). It belongs to the multitarget kinase inhibitor class and is used in selected advanced renal cell carcinoma and soft tissue sarcoma.
Active ingredient: Pazopanib
Strength: 200 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.